Nathaniel Fletcher Watson, MD

Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.

Expert panelists share their excitement for novel agents that may impact the insomnia treatment landscape.

A brief review of the unmet needs in insomnia management, particularly access to treatment and daytime functioning.

Practical considerations for selecting a particular agent or class when treating a patient with insomnia.

Shared insight on the pharmacologic treatment landscape of insomnia, with a focus on mainstay drug classes.

Focusing on the pharmacologic setting of insomnia, experts consider when it is best to initiate therapy.

Panelists review suboptimal over-the-counter medications that patients may use to manage insomnia.

A brief discussion on the use of mind and body practices to aid in the management of insomnia.

Expert perspectives on the benefits of and limitations to cognitive behavioral therapy for insomnia.

Focusing on treatment options for insomnia, experts consider the added value of sleep hygiene.

Panelists discuss the broad range of impact insomnia has on a patient’s health and quality of life.

A brief review of the value of polysomnography, or sleep studies, in diagnosing patients with insomnia.

A panel of experts break down the myriad of insomnia causes, discussing prevalence amid different patient populations.

Considerations for how to optimally work up and diagnose patients with insomnia.

Shared insight on how daytime functioning has become part of the insomnia treatment paradigm.

Expert perspectives on how patients may present differently with acute vs chronic insomnia.